WILEX successfully completes Phase II study with RENCAREX®* in combination with Interferon
/pressemitteilung/pdf/79226/meldung.pdf
/pressemitteilung/pdf/79226/meldung.pdf
/pressemitteilung/pdf/77455/meldung.pdf
Cenix BioScience GmbH (Dresden), the leading specialist in advanced RNA interference (RNAi)-based research services, and…
/pressemitteilung/pdf/73982/meldung.pdf
Signature Diagnostics has selected XClinical’s EDC-CDM system MARVIN to support a 6-year multi-centre diagnostic trial i…
Linear Technology Corporation announces the LTC3526, a 1MHz, current mode, synchronous boost DC/DC converter with output…
/pressemitteilung/pdf/73542/meldung.pdf
ProBioGen AG and Evotec Technologies GmbH have announced the successful completion of their collaboration - the joint ev…
JPK Instruments introduces the NanoWizard®II, the truly next generation AFM for biological and soft matter applications.…